In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae (Q73276445)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2000

Language	Label	Description	Also known as
English	In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae	scientific article published on 01 November 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

methicillin-resistant Staphylococcus aureus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R Patel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M S Rouse

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K E Piper

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J M Steckelberg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

177-179

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900193-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(00)00193-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11109018%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73276445&oldid=1743302938"